Multimodality therapy: Radiation and continuous concomitant cis-platinum and PKC inhibition in a cervical carcinoma model

Cancer Investigation

Volumn 16, Issue 7, 1998, Pages 462-470

  Sommers, Gara M ^a   Alfieri, Alan A ^b  

^a St Mary's Hospital   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 HYDROXYSTAUROSPORINE; ANTINEOPLASTIC AGENT; CISPLATIN; COBALT 60; PROTEIN KINASE C INHIBITOR;

ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; FEMALE GENITAL TRACT CANCER; GROWTH INHIBITION; HELA CELL; HUMAN; HUMAN CELL; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

EID: 0031708015     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909809011700     Document Type: Article

References (23)

1. Perez CA, Uterine cervix. In: Principles and Practice of Gynecologic Oncology, edited by Hoskins WJ, Perez CA, Young RC. Philadelphia, JB Lippincott, 1992, pp 591-662.
2. Montana GS, Fowler WC, Varia MA, et al: Carcinoma of the cervix; stage 111: results of radiation therapy. Cancer 57:148-154, 1986.
3. Kramer G, Deschel RE, Goldberg B, et al: Radiation treatment of FIGO stage IVA carcinoma of the cervix. Gynecol Oncol 32: 323-326, 1989.
4. Weppelmann B, Shingleton HM: Radiotherapeutic and Surgical Approaches to Advanced or Recurrent Cervical Cancer. In: Textbook of Gynecologic Oncology, edited by Blackledge BP, Jordan JA, Shingleton HM. London, WB Saunders, 1991, pp 369-382.
5. Thomas G, Dembo A, Gadalla T, et al: Concurrent chemoradiation in advanced cervical cancer. Gynecol Oncol 38:446-451, 1990.
6. Vermorken JB: The role of chemotherapy in squamous cell carcinoma of the uterine cervix: a review. Int J Gynecol Cancer 3:129, 1993.
7. Weinstein IB: The origins of human cancer: molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment. Cancer Res 48:4135, 1988.
8. Morrison DK, Kaplan DR, Rapp U, et al: Signal transduction from membrane to cytoplasm: growth factors and membrane bound oncogene products increase Raf-1 phosphorylation and associated protein kinase activity. Proc Natl Acad Sci USA 85:8855-8859, 1988.
9. Hallahan DE, Virudachalam S, Schwartz JL, et al: Inhibition of protein kinases sensitizes human tumor cells to ionizing radiation. Radiat Res 129:345-350, 1992.
10. Haimovitz-Friedman A, Balaban N, McLoughlin M, et al: Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. Cancer Res 2591-2597, 1994.
11. Alfieri AA, Chadha M, Traganos F, et al: Radiation sensitization by staurosporine associated with G2 induced division delay in A549 lung adenocarcinoma. Proc Am Assoc Cancer Res 35:635, 1994 (abstract).
12. Bruno S, Ardelt B, Skierski JS: Different effects of staurosporine, an inhibitor of protein kinases, on the cell cycle and chromatin structure of normal and leukemic lymphocytes. Cancer Res 51: 470-473, 1992.
13. Matsumoto H, Sasaki, Y. Staurosporine, a protein kinase C inhibitor, interferes with proliferation of arterial smooth muscle cells. Biochem Biophys Res Commun 158:105-109, 1989.
14. Sutherland, RM Sordat B, Bamat J. et al: Oxygenation and differentiation in multicellular spheroids of human colon carcinoma. Cancer Res 46:5320-5329, 1986.
15. Sutherland RM, McCredie JA, Inch WR: Growth of multicell spheroids in tissue culture as a model of nodular carcinoma. J Natl Cancer Inst 46:113-120, 1971.
16. He SQ, Kim SH, Kim JH: Interaction of radiation and AT1727 in Hela S-3 cells in culture. Int J Radiat Oncol Biol Phys 11:1137-1142, 1985.
17. Kim JH, Kim SH, He S, et al: Potentiation of radiation effects on multicellular tumor spheroids (MTS) of HeLa cells by lonidamine. Int J Radiat Oncol Biol Phys 16:1277-1280, 1989.
18. Schwartz GK, Haimovitz-Friedman A, Dhupar SK, et al: Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor Safingol in Mitomycin-C treated gastric cancer cells. J Natl Cancer Inst 87:1394-1399, 1995.
19. Driscoll D, Parek R, Hamby J. et al. Induction of apoptosis in HL60 by suramin and protein kinase inhibitors. Proc Am Assoc Cancer Res 37:17, 1996 (abstract).
20. Shao RG, Shimizu T, Pommier Y: 7-hydroxstaurosporine (UCN-01), a novel and potent inducer of apoptotic DNA fragmentation in human colon carcinoma and leukemia cells. Proc Am Assoc Cancer Res 37:17, 1996 (abstract).
21. Bunch RT, Brown MK, Eastman A. Abrogation of cisplatin induced cell cycle arrest and enhancement of cisplatin induced cytotoxicity by 7-hydroxy staurosporine (UCN-01), a new G2 checkpoint inhibitor. Proc. Amer. Assoc. Cancer Res. 37:3, 1996 (abstract).
22. Wang Q, Fan S, Eastman, A. et al: UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53. Proc Am Assoc Cancer Res 37:421, 1996 (abstract).
23. Pollack IF, Kaweck S, Rustk JM.: UCN-01, a selective protein kinase inhibitor, blocks glioma proliferation and induces apoptosis in vitro and inhibits glioma growth in vivo. Proc Am Assoc Cancer Res 37:424, 1996 (abstract).